Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis (Q45419013)

From Wikidata
Jump to navigation Jump to search
scientific article published in March 2013
edit
Language Label Description Also known as
English
Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
scientific article published in March 2013

    Statements

    Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis (English)
    M Bonelli
    E Ferner
    L Göschl
    S Blüml
    A Hladik
    H P Kiener
    B Niederreiter
    C W Steiner
    M Bergmann
    J S Smolen
    C Scheinecker
    1 March 2013
    599-607

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit